Session R.A. II's Form 4 filing
Taysha Gene Therapies, Inc. (TSHA) · filed Jun 22, 2023
- Accession no.
- 0000899243-23-016232
- Filed
- Jun 22, 2023
- Trade date
- Jun 20-21, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $307.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Session R.A. IICIK 0001701846 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 20, 2023 | Common Stock | SSaleDisposed | −295,653 | $0.71 | −$209,913.63 | 9,125,189 | Direct | |
| Jun 21, 2023 | Common Stock | SSaleDisposed | −138,962 | $0.70 | −$97,273.4 | 8,986,227 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.